Literature DB >> 20337547

Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus.

Alessandra Della Rossa1, A Tavoni, A D'Ascanio, E Catarsi, F Marchi, W Bencivelli, S Salvadori, P Migliorini, S Bombardieri.   

Abstract

OBJECTIVES: Mixed cryoglobulinaemia (MC) is a chronic small-vessel vasculitis. Shortly after the discovery of hepatitis C virus (HCV) in 1989, an association between HCV infection and MC was being increasingly reported, suggesting the potential pathogenetic implication of HCV in most of the cases that had been previously diagnosed as essential MC. A number of studies have pointed out prognostic factors linked to mortality in this disorder. None of them, however, have clarified the impact of HCV discovery on the natural history of the disease. The aim of the present study was to evaluate mortality in MC after the discovery of HCV infection.
METHODS: We retrospectively collected clinical and serological data in 70 unselected HCV-positive patients being followed up at our unit from 1990. Clinical and prognostic factors linked to poor outcome were evaluated.
RESULTS: Chronic hepatitis, renal involvement, and intestinal vasculitis were the most frequent causes of death.
CONCLUSION: Compared to other series, the outcome in our MC seemed to be better. Factors linked to a poor outcome were renal involvement, widespread vasculitis, male sex, and cryocrit.

Entities:  

Mesh:

Year:  2010        PMID: 20337547     DOI: 10.3109/03009740903313639

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  8 in total

1.  Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis.

Authors:  Mohamad Zaidan; Eric Mariotte; Lionel Galicier; Bertrand Arnulf; Véronique Meignin; Jérôme Vérine; Alfred Mahr; Elie Azoulay
Journal:  Ann Intensive Care       Date:  2012-07-19       Impact factor: 6.925

2.  An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia.

Authors:  Gurdeep Singh Mannu
Journal:  JRSM Short Rep       Date:  2010-11-22

Review 3.  Understanding the Cryoglobulinemias.

Authors:  Alejandro Fuentes; Claudia Mardones; Paula I Burgos
Journal:  Curr Rheumatol Rep       Date:  2019-11-19       Impact factor: 4.686

4.  Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients.

Authors:  Vladimir Coliche; Marie-Nathalie Sarda; Maurice Laville; Roland Chapurlat; Sylvain Rheims; Pascal Sève; Clémence Théry-Casari; Jean-Christophe Lega; Denis Fouque
Journal:  Clin Kidney J       Date:  2018-11-09

5.  Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals.

Authors:  Qianyu Guo; Jinfang Gao; Jiaoniu Duan; Ruihong Hou; Tsung-Hsueh Lu; Liyun Zhang
Journal:  Arthritis Res Ther       Date:  2022-02-12       Impact factor: 5.156

6.  Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.

Authors:  Soledad Retamozo; Cándido Díaz-Lagares; Xavier Bosch; Albert Bové; Pilar Brito-Zerón; Maria-Eugenia Gómez; Jordi Yagüe; Xavier Forns; Maria C Cid; Manuel Ramos-Casals
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

7.  Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study.

Authors:  Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno; Franco Dammacco; Domenico Sansonno
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

8.  Correction of fertility disorders in patients with cryoglobulinemia.

Authors:  Borys Gerasun; Roman Kopets; Roman Hrytsko; Oleksandr Gerasun
Journal:  Cent European J Urol       Date:  2013-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.